Brain Cancer

Learn about awareness and actions strategies during Brain Tumor Awareness Month and beyond.

From the first annual Glioblastoma Awareness Day to politics and today’s top performers, here’s what’s making headlines in the cancer space this week.​

Carrying chronic illness can be very difficult, but there are ways to navigate the world without being crushed by the weight of what we cannot control.

Children diagnosed with embryonal brain tumors who have experienced treatment-related hearing loss exhibited greater difficulties reading – in particular, with phonological skills and processing speed, according to study results.

From National Women's Health Week to today’s top athletes, here’s what’s making headlines in the cancer space this week.

The phase 3 CheckMate 498 trial, designed to compare Opdivo with Temodal for the treatment of patients with newly diagnosed O6-methylguanine-DNA methyltransferase (MGMT)-unmethylated glioblastoma multiforme failed to meet its primary endpoint of increasing overall survival.

From a sweet fundraiser for breast cancer to today’s top performers and athletes, here’s what’s making headlines in the cancer space this week.

Evaluations can identify the potential for drug interactions and predict whether older patients are fit for chemotherapy.

Researchers examine genomic mutations with tumor response to Keytruda and Opdivo in patients with GBM, highlighting the potential for a molecular, personalized approach to treat certain patients.

Patients with glioblastoma may lack easy access to clinical trials and off-label treatments, despite showing an interest in learning more about them.

Administration of Opdivo (nivolumab) before surgical resection in patients with glioblastoma appeared safe and feasible, according to phase 2 trial results published in Nature Medicine.

The Food and Drug Administration (FDA) Expanded Access program appeared to have broad use, involved a wide variety of patients and drugs, and derived clinical benefit, according to an initial summary published in JAMA Oncology.

A preclinical study showed that FGL2 protein suppression may stop tumor cell growth in patients with glioblastoma.

Here are the top 5 CURE stories for January 2019.

Penn Medicine launches program that allows people with brain tumors to access remote medical plans.

A man with glioblastoma has received Gliovac (ERC1671) under legislation allowing for the terminally ill to try experimental drugs that have passed preliminary FDA testing.

Since being diagnosed, I've learned a tremendous amount in my journey.

Inhibiting the immune system could decrease cognitive decline after radiation treatment, according to research conducted in mouse models.

When a diagnosis begins to improve, it is hard to reconcile your identity as a patient with your identity as a whole. Grappling with questions of who you are after having been diagnosed with something life altering can be both profound and challenging, and leave you a bit, well, ambivalent.

As a mom, I honestly cannot think of anything more terrifying than a cancer diagnosis in one of my kids. This article takes a deep look at brain tumors in children

As with cancers that affect the liver, cancers that hit the brain and nervous system can be broadly broken down into primary tumors and secondary tumors. A primary brain or nervous system tumor is one that arises from tissues in the brain and nervous system

Once you or someone you love has been diagnosed with something big, the times between scans become sacred in-between times where you do your best to live in light of the ever-changing circumstances of your body. Sometimes that can be a time full of fear, but others it is a time full of hope.

The cognitive dysfunction that patients with glioblastoma often face can compound these challenges and ultimately put extra stress on caregivers.

Researchers have found a potentially safer and faster way to determine if treatment for a type of childhood brain cancer is working.

Health care shouldn't be a fight, but it is. I tell my story of fighting for an MRI in a hope that I illuminate the cracks in our system in a hope we can make change, so no one falls through those cracks.

In the first such clinical trial in the United States, researchers will evaluate focused ultrasound to breach the blood-brain barrier

Children who suffer from a highly aggressive and deadly type of brain tumor may have new hope when it comes to treatment options.

Brain cancer survivors are living longer, highlighting the importance of survivorship care for this population.

A recent study from St. Jude Children’s Hospital found that more than half of adults who survived pediatric central nervous system tumors failed to achieve independence as adults.

“Key brain regions that we know are typically involved in autobiographical memory formation and retrieval, especially the hippocampus, are located quite far from the primary tumor bed, and thus far from the site of focal radiation,” Sekeres, who is director of the Sekeres Memory Laboratory at Baylor University, said in an interview with CURE.